X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-28 | MDXG | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale+OE | $8.41 | -2,111 | 314,942 | -1% | -$17,743 | |||||
2025-02-13 | MDXG | Whitlow Ricci S | COO | S - Sale | $8.28 | -61,420 | 403,019 | -13% | -$508,558 | ||||||
2024-03-13 | MDXG | Hulse William Frank IV | GC, CAO | S - Sale | $7.95 | -20,381 | 479,959 | -4% | -$162,029 | ||||||
| M | 2024-02-16 | MDXG | Whitlow Ricci S | COO | S - Sale | $8.04 | -30,764 | 401,050 | -7% | -$247,426 | |||||
| M | 2024-02-14 | MDXG | Whitlow Ricci S | COO | S - Sale | $8.05 | -31,043 | 431,814 | -7% | -$249,763 | |||||
2023-11-21 | MDXG | Doug Rice | CFO | P - Purchase | $7.16 | +5,000 | 102,200 | +5% | +$35,787 | ||||||
| M | 2023-06-22 | MDXG | Capper Joseph H | CEO | P - Purchase | $6.40 | +100,000 | 100,000 | New | +$640,434 | |||||
| M | 2023-05-15 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med. | S - Sale | $6.00 | -13,972 | 317,803 | -4% | -$83,798 | |||||
2023-05-10 | MDXG | Hulse William Frank IV | GC, CAO | S - Sale | $5.93 | -5,870 | 456,564 | -1% | -$34,786 | ||||||
2023-05-10 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med. | S - Sale | $5.93 | -5,869 | 331,775 | -2% | -$34,780 | ||||||
2023-05-10 | MDXG | Phelan William Lawrence | Chief Accounting Officer | S - Sale | $5.93 | -1,595 | 184,219 | -1% | -$9,452 | ||||||
2023-05-10 | MDXG | Carlson Peter M | CFO | S - Sale | $5.93 | -5,976 | 656,435 | -1% | -$35,414 | ||||||
2023-05-04 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med. | S - Sale | $5.34 | -51,756 | 337,644 | -13% | -$276,470 | ||||||
2023-05-02 | MDXG | Phelan William Lawrence | Chief Accounting Officer | S - Sale | $3.80 | -5,200 | 185,814 | -3% | -$19,739 | ||||||
2023-04-25 | MDXG | Phelan William Lawrence | Chief Accounting Officer | S - Sale | $3.74 | -1,628 | 191,014 | -1% | -$6,095 | ||||||
2023-04-25 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med. | S - Sale | $3.74 | -5,987 | 389,400 | -2% | -$22,415 | ||||||
2023-04-25 | MDXG | Hulse William Frank IV | GC, CAO | S - Sale | $3.74 | -5,988 | 462,434 | -1% | -$22,419 | ||||||
2023-04-25 | MDXG | Carlson Peter M | CFO | S - Sale | $3.74 | -6,094 | 662,411 | -1% | -$22,816 | ||||||
2023-04-11 | MDXG | Phelan William Lawrence | Chief Accounting Officer | S - Sale | $3.31 | -1,632 | 192,642 | -1% | -$5,402 | ||||||
2023-04-11 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med. | S - Sale | $3.31 | -5,996 | 395,387 | -1% | -$19,847 | ||||||
2023-04-11 | MDXG | Hulse William Frank IV | GC, CAO | S - Sale | $3.31 | -5,995 | 468,422 | -1% | -$19,843 | ||||||
2023-04-11 | MDXG | Carlson Peter M | CFO | S - Sale | $3.31 | -6,100 | 668,505 | -1% | -$20,191 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |